Publications & Works

Publication Network
Articles 20
All (20)
SCI-E, SSCI, AHCI (17)
SCI-E, SSCI, AHCI, ESCI (17)
Scopus (19)
Other Publications (1)

1. Cold plasma triggered cell death with a curcumin and capecitabine loaded magnetic nanocluster-based multifunctional system on the MCF-7 cell line: a smart therapy platform

Erdag D., Garrido M. D., BAŞOĞLU H., Yazgan I., Amoros P., YALÇINTEPE GÜNEŞTUTAR L., et al.
JOURNAL OF MATERIALS CHEMISTRY B , vol.14, no.4, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

2. Novel ionic liquids with antibacterial and low cytotoxic properties for double-J stents

Alhomsi O., Yalcintepe L., Atalay V. E., Swellam T., GÜNÇER B.
UROLITHIASIS , vol.53, no.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

3. Synergistic effect of selenium and genipin triggers viability of 3T3 cells on PVA/Gelatin scaffolds.

Erdag D., Koc S. N., Oksuzomer M. F., Yalcintepe L.
Acta of bioengineering and biomechanics , vol.24, no.1, pp.179-190, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

4. The effect of iron on the expression levels of calcium related gene in cisplatin resistant epithelial ovarian cancer cells

Kucukkaya B., Erdag D., AKBAŞ F., Yalcintepe L.
Exploration of Targeted Anti-tumor Therapy , vol.2, no.4, pp.309-322, 2021 (Scopus) identifier identifier

5. Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells

Yalcintepe L., Erdag D., AKBAŞ F., Kucukkaya B.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , vol.47, no.7, pp.1221-1230, 2020 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

6. Calcium homeostasis in cisplatin resistant epithelial ovarian cancer.

Kucukkaya B., Basoglu H., Erdag D., AKBAŞ F., SÜSGÜN S., Yalcintepe L.
General physiology and biophysics , vol.38, no.4, pp.353-363, 2019 (SCI-Expanded) Sustainable Development identifier identifier identifier

7. Kanser Hücrelerinde Hücre İçi Kalsiyum Hareketlerinin Bileşenleri

YALÇINTEPE GÜNEŞTUTAR L.
Turkiye Klinikleri J Med Sci , vol.37, no.2, pp.98-108, 2017 (Scopus) Sustainable Development

8. Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin.

Yalcintepe L., Halis E., Ulku S.
Oncology letters , vol.11, no.3, pp.2290-2296, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

9. Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin

Yalcintepe L., Halis E.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , vol.16, no.1, pp.14-20, 2016 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

10. Characterization of Lin(-)ALDH(bright) population using Ehrlich ascites tumor cells in mice

Yalcintepe L., Altinel P., Albeniz I., Yilmaz A., Nurten R.
TUMOR BIOLOGY , vol.35, no.10, pp.10363-10373, 2014 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

11. Elektroforezde Yeni Yaklaşımlar

GÜNEŞTUTAR L.
Sigma (YTU, Mühendislik ve Fen Bilimleri Dergisi) , vol.27, no.2, pp.151-160, 2009 (Peer-Reviewed Journal)

12. Erythrocyte CD38 as a prognostic marker in cancer

Albeniz I., Demir O., Tuerker-Sener L., Yalçıntepe L., Nurten R., Bermek E.
HEMATOLOGY , vol.12, no.5, pp.409-414, 2007 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

13. Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice.

Yalcintepe L., Frankel A., Hogge D.
Blood , vol.108, no.10, pp.3530-7, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

14. Nitric oxide levels during erythroid differentiation in K562 cell line.

Kucukkaya B., Ozturk G., Yalcintepe L.
Indian journal of biochemistry & biophysics , vol.43, no.4, pp.251-3, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

15. Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.

Hogge D., Yalcintepe L., Wong S., Gerhard B., Frankel A.
Clinical cancer research : an official journal of the American Association for Cancer Research , vol.12, no.4, pp.1284-91, 2006 (SCI-Expanded) identifier identifier identifier

16. Changes in metabolism NAD/ADP-ribose in rectal cancer

Yalcintepe L., Turker-Sener L., Sener A., Yetkin G., Tiryaki D., Bermek E.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH , vol.38, no.3, pp.361-365, 2005 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

17. Nuclear CD38 in retinoic acid-induced HL-60 cells.

Yalcintepe L., Albeniz I., Adin-Cinar S., Tiryaki D., Bermek E., Graeff R., et al.
Experimental cell research , vol.303, no.1, pp.14-21, 2005 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

18. Hemin-dependent induction and internalization of CD38 in K562 cells.

Yalcintepe L., Ercelen S., Adin-Cinar S., Badur S., Tiryaki D., Bermek E.
Journal of cellular biochemistry , vol.90, no.2, pp.379-86, 2003 (SCI-Expanded) Sustainable Development identifier identifier identifier

19. Serum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity--elevated levels in serum of tumour patients.

Korkut C., Yalcintepe L., Kiremit-Korkut N., Uzun-Altinoz S., Issever S., Gumusel F., et al.
Cancer letters , vol.126, no.1, pp.105-9, 1998 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

20. Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells.

Boulton S., Kyle S., Yalçintepe L., Durkacz B.
Carcinogenesis , vol.17, no.11, pp.2285-90, 1996 (SCI-Expanded) identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 4

1. NAD Metabolism in Breast Cancer

GÜNEŞTUTAR L.
Febs Journal, Budapeşte, Hungary, 3 - 07 July 2005, pp.272 Sustainable Development

2. The use of mouse models of normal and malignant hematopoiesis to design strategies for selective purging of primitive AML progenitor.

GÜNEŞTUTAR L.
Tandem BMT, Biology of Blood and Marrow Transplantation, Keystone,Colorado, United States Of America, 10 - 14 February 2005, pp.105, (Full Text)

3. The use of mouse models of normal and malignant hematopoiesis to design strategies for selective purging of primitive acute myeloid leukemia (AML) progenitors

Hogge D., Wong S., YALÇINTEPE GÜNEŞTUTAR L., Frankel A.
Joint Meeting of the American-Society-for-Blood-and-Marrow-Transplantation/Center-for-International-Blood-and-Marrow-Transplant-Research, Colorado, United States Of America, 10 - 14 February 2005, vol.11, pp.60, (Summary Text) identifier

4. Serum and Erytrocyte NAD Glycohydrolase Activity in Cancer Disease

GÜNEŞTUTAR L.
4th İnt. Symposium on Predictive Oncology and Therapy, Nice, France, 24 - 27 October 1998, pp.105, (Full Text) Sustainable Development
Books 2

1. Bütünleştirilmiş Molekülsel Ve Hücresel Biyofizik

Nurten A., Albeniz I., Yalçıntepe Güneştutar L., Akçakaya H., Bektaş M., Varol B., et al.
İstanbul Tıp Kitabevi, İstanbul, 2014

2. Molekülsel Makinaların Yapı ve İşlevi

GÜNEŞTUTAR L.
in: Bütünleştirilmiş Molekülsel ve Hücresel Biyofizik, Rustem Nurten, Editor, Nobel, İstanbul, pp.173-216, 2014
Metrics

Publication

26

Publication (WoS)

18

Publication (Scopus)

19

Citation (WoS)

270

H-Index (WoS)

8

Citation (Scopus)

285

H-Index (Scopus)

8

Project

14

Thesis Advisory

2

Open Access

2
UN Sustainable Development Goals